Skip to content
Search

Latest Stories

PHE warns of increased risk of malaria amidst Covid-19 travel plans

As international travel starts to recover amidst Covid-19 pandemic, the need to ensure protection against malaria for all those potentially exposed will be as great as ever, the Public Health England (PHE) advisory committee on malaria prevention (ACMP) has said in an update on Thursday (June 10).

The PHE body added that it “will keep its advice for travellers to individual countries under review as the situation evolves.


“It may be that due to increased transmission, the risk of malaria acquisition increases for travellers to some areas, with the possibility of re-introduction of malaria to areas recently considered to have interrupted transmission.”

The PHE has recommended health professionals stick to using one resource for country-specific malaria recommendations to optimise consistency of advice. “Whilst we recognise that other sources of advice are available, healthcare professionals working in England, Wales or Northern Ireland are advised to use the ACMP guidelines as their preferred source of guidance for malaria prevention,” the ACMP said in its latest guidance.

The Covid-19 has had a dramatic effect on travel patterns which has inevitably affected the number of malaria cases imported into the UK.

From the second quarter of 2020 onwards the malaria reference laboratory has seen a 70 to 90 per cent reduction in referred cases.

“The full effect of Covid-19 on in-country malaria eradication programmes has yet to be determined, but there are concerns that hard-won gains may be lost,” the PHE said.

The WHO world malaria report 2020 indicates that many countries have reported moderate levels of disruptions.

From modelling data, they estimate that in sub-Saharan Africa, reduction in access to effective antimalarial treatment of 10 per cent could lead to an additional 19,000 deaths by the end of 2020.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less